289 related articles for article (PubMed ID: 23003678)
1. Use of complementary and alternative medicine in patients with inflammatory bowel disease: results of a cross-sectional study in Norway.
Opheim R; Bernklev T; Fagermoen MS; Cvancarova M; Moum B
Scand J Gastroenterol; 2012 Dec; 47(12):1436-47. PubMed ID: 23003678
[TBL] [Abstract][Full Text] [Related]
2. Complementary and alternative medicine in patients with inflammatory bowel disease: the results of a population-based inception cohort study (IBSEN).
Opheim R; Hoivik ML; Solberg IC; Moum B;
J Crohns Colitis; 2012 Apr; 6(3):345-53. PubMed ID: 22405172
[TBL] [Abstract][Full Text] [Related]
3. [Treatment adherence and use of complementary and alternative medicine in patients with inflammatory bowel disease].
Lakatos L; Czeglédi Z; Dávid G; Kispál Z; Kiss LS; Palatka K; Kristóf T; Molnár T; Salamon A; Demeter P; Miheller P; Szamosi T; Banai J; Papp M; Bene L; Kovács A; Rácz I; Lakatos PL
Orv Hetil; 2010 Feb; 151(7):250-8. PubMed ID: 20133244
[TBL] [Abstract][Full Text] [Related]
4. Association of adherence to therapy and complementary and alternative medicine use with demographic factors and disease phenotype in patients with inflammatory bowel disease.
Lakatos PL; Czegledi Z; David G; Kispal Z; Kiss LS; Palatka K; Kristof T; Nagy F; Salamon A; Demeter P; Miheller P; Szamosi T; Banai J; Papp M; Bene L; Kovacs A; Racz I; Lakatos L
J Crohns Colitis; 2010 Sep; 4(3):283-90. PubMed ID: 21122517
[TBL] [Abstract][Full Text] [Related]
5. Complementary and alternative medicine in inflammatory bowel disease patients: frequency and risk factors.
Fernández A; Barreiro-de Acosta M; Vallejo N; Iglesias M; Carmona A; González-Portela C; Lorenzo A; Domínguez-Muñoz JE
Dig Liver Dis; 2012 Nov; 44(11):904-8. PubMed ID: 22795615
[TBL] [Abstract][Full Text] [Related]
6. Complementary medicine use by patients with inflammatory bowel disease.
Hilsden RJ; Scott CM; Verhoef MJ
Am J Gastroenterol; 1998 May; 93(5):697-701. PubMed ID: 9625111
[TBL] [Abstract][Full Text] [Related]
7. Use and predictors of oral complementary and alternative medicine by patients with inflammatory bowel disease: a population-based, case-control study.
Koning M; Ailabouni R; Gearry RB; Frampton CM; Barclay ML
Inflamm Bowel Dis; 2013; 19(4):767-78. PubMed ID: 23429459
[TBL] [Abstract][Full Text] [Related]
8. Patterns of complementary and alternative medicine (CAM) use in patients with inflammatory bowel disease: perceived stress is a potential indicator for CAM use.
Langhorst J; Anthonisen IB; Steder-Neukamm U; Luedtke R; Spahn G; Michalsen A; Dobos GJ
Complement Ther Med; 2007 Mar; 15(1):30-7. PubMed ID: 17352969
[TBL] [Abstract][Full Text] [Related]
9. The Manitoba Inflammatory Bowel Disease Cohort Study: a prospective longitudinal evaluation of the use of complementary and alternative medicine services and products.
Rawsthorne P; Clara I; Graff LA; Bernstein KI; Carr R; Walker JR; Ediger J; Rogala L; Miller N; Bernstein CN
Gut; 2012 Apr; 61(4):521-7. PubMed ID: 21836028
[TBL] [Abstract][Full Text] [Related]
10. Characterisation of complementary and alternative medicine use and its impact on medication adherence in inflammatory bowel disease.
Weizman AV; Ahn E; Thanabalan R; Leung W; Croitoru K; Silverberg MS; Steinhart AH; Nguyen GC
Aliment Pharmacol Ther; 2012 Feb; 35(3):342-9. PubMed ID: 22176478
[TBL] [Abstract][Full Text] [Related]
11. Complementary medicine use in children and young adults with inflammatory bowel disease.
Heuschkel R; Afzal N; Wuerth A; Zurakowski D; Leichtner A; Kemper K; Tolia V; Bousvaros A
Am J Gastroenterol; 2002 Feb; 97(2):382-8. PubMed ID: 11866277
[TBL] [Abstract][Full Text] [Related]
12. Cannabis use amongst patients with inflammatory bowel disease.
Lal S; Prasad N; Ryan M; Tangri S; Silverberg MS; Gordon A; Steinhart H
Eur J Gastroenterol Hepatol; 2011 Oct; 23(10):891-6. PubMed ID: 21795981
[TBL] [Abstract][Full Text] [Related]
13. Regional variations in the use of complementary and alternative medicines (CAM) for inflammatory bowel disease patients in Italy: an IG-IBD study.
Bertomoro P; Renna S; Cottone M; Riegler G; Bossa F; Giglio L; Pastorelli L; Papi C; Castiglione F; Angelucci E; Pica R; Di Paolo MC; D'Incà R
J Crohns Colitis; 2010 Sep; 4(3):291-300. PubMed ID: 21122518
[TBL] [Abstract][Full Text] [Related]
14. [Status of alternative medicine in Crohn disease and ulcerative colitis patents: a questionnaire survey].
Ausfeld-Hafter B; Hoffmann S; Seibold F; Quattropani C; Heer P; Straumann A
Forsch Komplementarmed Klass Naturheilkd; 2005 Jun; 12(3):134-8. PubMed ID: 15985776
[TBL] [Abstract][Full Text] [Related]
15. Use of complementary and alternative medicines by children and adolescents with inflammatory bowel disease.
Day AS; Whitten KE; Bohane TD
J Paediatr Child Health; 2004 Dec; 40(12):681-4. PubMed ID: 15569284
[TBL] [Abstract][Full Text] [Related]
16. Work disability in inflammatory bowel disease patients 10 years after disease onset: results from the IBSEN Study.
Høivik ML; Moum B; Solberg IC; Henriksen M; Cvancarova M; Bernklev T;
Gut; 2013 Mar; 62(3):368-75. PubMed ID: 22717453
[TBL] [Abstract][Full Text] [Related]
17. The association between inflammatory bowel disease and periodontitis among Jordanians: a case-control study.
Habashneh RA; Khader YS; Alhumouz MK; Jadallah K; Ajlouni Y
J Periodontal Res; 2012 Jun; 47(3):293-8. PubMed ID: 22050539
[TBL] [Abstract][Full Text] [Related]
18. Complementary and alternative medications consumed by renal patients in southern Germany.
Nowack R; Ballé C; Birnkammer F; Koch W; Sessler R; Birck R
J Ren Nutr; 2009 May; 19(3):211-9. PubMed ID: 19251442
[TBL] [Abstract][Full Text] [Related]
19. Association Between Complementary and Alternative Medicine Use and Breast Cancer Chemotherapy Initiation: The Breast Cancer Quality of Care (BQUAL) Study.
Greenlee H; Neugut AI; Falci L; Hillyer GC; Buono D; Mandelblatt JS; Roh JM; Ergas IJ; Kwan ML; Lee M; Tsai WY; Shi Z; Lamerato L; Kushi LH; Hershman DL
JAMA Oncol; 2016 Sep; 2(9):1170-6. PubMed ID: 27243607
[TBL] [Abstract][Full Text] [Related]
20. Amount of systemic steroid medication is a strong predictor for the use of complementary and alternative medicine in patients with inflammatory bowel disease: results from a German national survey.
Langhorst J; Anthonisen IB; Steder-Neukamm U; Lüdtke R; Spahn G; Michalsen A; Dobos GJ
Inflamm Bowel Dis; 2005 Mar; 11(3):287-95. PubMed ID: 15735435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]